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ABSTRACT
Purpose: To evaluate the hepatic effect of Croton cajucara Benth (sacaca) herbal extract in rats. Methods: 60 Wistar rats
(Rattus novergicus albinus) were used, weighing between 250 and 350 g. The animals were distributed randomically in 2
groups: GS – animals which received daily 0,1 ml/ 100 g of sacaca herbal extract through gavage, and GA –animals which
received daily 0,1 ml/100g of distilled water through gavage. These were distributed in 3 subgroups with 10 animals,
according to theirs euthanasia dates, which were 14th, 28th and 56th day of treatment. Results: Architectural alterations
were not observed, however when it was analyzed the presence or absence of necrosis, it was observed in 50% of GS28
subgroup and 90% of subgroup. In 50% of the animals from GS28 subgroup and 90% of GS56 subgroup was observed vast
degeneration areas and zonal necrosis, regarding center-lobular veins alterations, there were no alterations in any of the
groups Conclusion: The Croton cajucara Benth (sacaca) herbal extract in this experiment caused degeneration and
hepatic necrosis, suggesting dose-dependent action.
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RESUMO
Objetivo: Avaliar histologicamente os efeitos do infuso, por gavagem, do Extrato Bruto Aquoso Seco (EBAS) do Croton
cajucara Benth no fígado de ratos. Métodos: Foram utilizados 60 ratos (Rattus novergicus albinus Wistar), pesando entre
250 e 350g. Os animais foram distribuídos de maneira aleatória em 2 grupos: GS – Grupo de animais que receberam 0,1ml/
100g do infuso de sacaca, pela via oral e GA – Grupo de animais que recebeu 0,1ml/100g de água destilada, pela via oral.
Estes foram distribuídos em 3 subgrupos de acordo com o dia da eutanásia, sendo esta realizada no 14º, 28º e 56º dia, cada
um com 10 animais. Resultados: Os resultados obtidos demonstraram que, microscopicamente, não houve alterações
arquiteturais, porém quando se analisou a necrose hepatocitária, esta esteve presente em 50% do subgrupo GS28 e 90% do
subgrupo GS56; as alterações inflamatórias puderam ser observadas tanto no subgrupo GS28 como no subgrupo GS56,
sendo que neste último se fez presente em 80%, enquanto que no primeiro em apenas 20% dos animais submetidos ao
experimento; 50% dos animais do subgrupo GS28 e 90% dos do subgrupo GS56 apresentaram extensa área de degeneração
e necrose focal do hepatócito; em 100% dos animais tanto do GA como do GS não apresentaram qualquer alteração da veia
centro-lobular. Conclusão: O infuso de Croton cajucara Benth (sacaca), nas condições deste experimento, foi capaz de
determinar degeneração e necrose hepatocitária, sugerindo que a hepatotoxicidade à sacaca é dose dependente.
Descritores: Plantas Medicinais. Fígado. Medicamentos Fitoterápicos. Ratos.
1. Research performed from Experimental Surgery Laboratory, State University of Pará (UEPA), Brazil.
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Introduction
Croton cajuraca Benth (sacaca), a vegetal specie
from Amazon region, is widely used by the local population
to treat gastrointestinal conditions,1 but it can cause hepatic
disfunction, and in some cases fulminant hepatitis.2,3
Medicine improvements provided a fantastic growth
of drugs currently available to treat and control many
diseases. In order to make it possible, scientists, besides
developing synthetic drugs, focused into the popular
medicine, researching many plants used empirically to
treatment of many diseases, aiming the extraction of theirs
active principles and the development of new drugs.4,5
The popular medicine was sovereign during many
centuries, but was replaced, in 20th century, by tested and
proven drugs. However population kept faithful to some
traditional medicines, even if those are not scientifically
proven, as well as it is not known their toxicity, side effects
and indications. 6,7
According to World Health Organization, 80% of the
population uses the popular medicine, because they believe
medicinal plants to be an “innocuous” medicine, with less
side effects than the allopathic.8,9
It must be noticed that, to the population nature
products are unlikely to cause any harm and it is difficult to
resist the seducing promises they offer, as well as its
supposed efficacy, and mostly because popular medicine
drugs are free or have a low cost, affordable to most of their
users. 10,11
Brazil and specially the Amazon region is considered
the widest natural reserve from the planet and still preserve
a little of Indians’ culture, therefore showing the possibility
of a wide use of drugs from natural sources.12,13
However, its use must be done carefully, since many
of these plants taken as medicines, are highly toxic and
many times with unexpected side effects, like hepatitis
development caused by sacaca’s chronic use, causing death
due to that.14
The connection between hepatotoxicity and sacaca
became notable in the Amazon region, mainly after its
commercialization as a medicine to weight and
cholesterolemia control.  9,15
Since sacaca is widely used by population and since
it is not fully known its risks, we believe it is necessary to
evaluate the microscopic effects of Croton cajucara Benth
herbal extract on rats’ livers.
Methods
Sixty Wistar rats (Rattus novergicus albinus),
males, adults, weighing between 250 and 350g, derived from
 Evandro Chagas Institute (Belém – Pará) and adapted to
the Surgery Experimental Laboratory from State University
of Pará (LCE-UEPA) for a period of fifteen days. Animals
 were kept under standard rodent laboratory housing at
conditions with 12 hours day/night cycles and given
standard rodent chow diets and tap water ad libitum.
The animals were distributed aleatorically in two
groups, according to the substances used:
Sacaca Group (GS): animals which received daily 0,1
ml/ 100 g of sacaca herbal extract through gavage.
Water Group (GA): animals which received daily 0,1
ml/100g of distilled water through gavage.
Each group was then subdivided in three subgroups
each one with 10 animals, according to theirs euthanasia
dates, which were 14th, 28th and 56th day of treatment.
Procedures
The sacaca leaves used in this study were obtained
from the Brazilian Agency of Agriculture and Pecuary
(EMBRAPA), dehydrated in oven in 45°C for 24 hours and
grinded to obtain its powder that in the Pharmacology
Laboratory from State University of Pará was used to obtain
the herbal aquous extract.
Before the gavage the animals were weighed and the
dosage of herbal extract calculated. The assigned drugs
(water or sacaca) were given to each group at nighttime
during 14, 28 or 56 days, according to each subgroup.
In predetermined days, 14th, 28th, and 56th, animals
were euthanized by an excessive inhalation of diethylether
and their livers were removed. Then, the left lobe was cut in
0,5cm slices and put in closed recipients, with tamponated
formaldehyde at a 10% concentration for five days, and
sent to the histopathologic processing and analysis.
The microscopic analysis was made with histological
cuts of 5 micrometers, counter stained with hematoxilin and
eosine, and their reading was made using an optical
microscope NIKON-YS2-T.
The data obtained was registered in standardized
protocols and analyzed by Fisher’s exact test and by chi-
square test. P values < 0.05 were taken to indicate statistical
significance.
Results
Architectural alterations were present in only one
animal from GS56 subgroup (3,3%). In group GA none of
the animals had alterations (Table 1).
TABLE 1 — Presence or absence of architectural alterations in liver cuts of animals
treated with water (GA) and sacaca (GS), according to each subgroup
TREATMENT DAY 14                       DAY 28                             DAY 56
                            presence     absence    presence     absence     presence     absence
Water                        0                10                 0                 10                  0             10
Sacaca        0                10         0                 10                   1                 9
Source: Work Evaluation Protocol.
P > 0,05
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When was analyzed the presence or absence of
necrosis, it was observed that one animal from the GA28
subgroup presented liver cells necrosis, while half of the
animals from GS28 subgroup and almost all from GS56
subgroup had areas of coagulative necrosis (Table 2).
TABLE 2 — Presence or absence of necrosis in liver cuts of animals treated with water (GA) and
sacaca (GS), according to each subgroup
TREATMENT DAY 14                                        DAY 28                               DAY 56
                           presence   absence              Presence*     absence         Presence* absence
Water                      0 10                        1                9             0                   10
Sacaca      0                    10                   5                      5             9                     1
Source: Work Evaluation Protocol
P*<0,05 (Qui-quadrado test)
The microscopic analysis from GS28 and GS56
subgroups showed that inflammatory infiltration increases
as the time of the drug administrations lengthens, fact that
could be observed majorly in GS56 subgroup, where 80%
of the animals had inflammatory alterations (Table 3).
TABLE 3 — Presence or absence of inflammatory infiltration in liver cuts of animals treated with
water (GA) and sacaca (GS), according to each subgroup
TREATMENT DAY 14 DAY 28                                DAY 56
                         presence     absence                   Presence*   absence            Presence*     absence
Water                 0                     10                                  0                10               0                  10
Sacaca 0                     10                        2                   8               8                    2
Source: Work Evaluation Protocol
P*<0,05 (Qui-quadrado test)
In 50% of the animals from GS28 subgroup and 90%
of GS56 subgroup was observed vast degeneration areas
and zonal necrosis, with few inter-cytoplasmatic cholestasis
areas and dispersed congestion focus, characterizing drug-
induced hepatitis; at the control group, GA28 subgroup,
one animal also presented hepatitis, which could be related
to a previous hepatic lesion (Table 4).
TABLE 4 — Presence and absence of hepatocellular degenerative alterations in liver cuts of
animals treated with water (GA) and sacaca (GS), according to each subgroup
TREATMENT DAY 14 DAY 28                            DAY 56
                            presence   absence                  Presence*    absence        Presence* absence
Water                         0               10                             1                 9             0       10
Sacaca         0               10                      5                     5             9                      1
Source: Work Evaluation Protocol
P*<0,05 (Qui-quadrado test)
Regarding center-lobular veins alterations, there
TABLE 5 — Presence or absence of alterations in the center-lobular veins in liver cuts of
animals treated with water (GA) and sacaca (GS), according to each subgroup
TREATMENT DAY 14 DAY 28                             DAY 56
                           presence    absence                   Presence*   absence         Presence* absence
Water                     0                  10                               0                10             0      10
Sacaca     0                  10                       0                   10             0                   10
Source: Work Evaluation Protocol
were no alterations in any of the groups (Table 5).
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Discussion
The Amazonic popular medicine presents many
substances with extent indications that were inherited by
the Indian culture. Among them, we emphasize sacaca. This
specie has registers of many isolated active principles as
“dehydrocrotonin, cajucarinolide and isocajucarinolide,
cajucarin A and B, diterpene clerodane, linalol”, among
others. The bark and the leaves of sacaca are used by the
population as teas, oil, capsules, pills, extracts, pure or mixed
with other substances. 2,16,17
The quantity of drugs given to each animal was
calculated based in data found on the package of medicines
sold in pharmacies and adapted to each rat according to the
its weight..
The appearance of architectural alterations was an
isolated fact, which could correspond to a chronic lesion or
a malformation, so there is no intimate relation with the
experiment, since architectural alterations in hepatic cells
are intimately related to a chronic injury of the organ.
Most of the animals that received sacaca had
hepatocellular necrosis that with long term drug
administration can determine hepatitis, since the ingestion
of drugs through a long period is stated by several authors
as being one of the most important factors of hepatic
necrosis.18 Also, diterpenoids are shown to cause liver injury
in animal models, as fully demonstrated on germander-
induced hepatitis.19
Inflammatory alterations appear as the drugs’
ingestion period lengthens, suggesting the fact that
hepatocyte suffering is directly proportional to the drugs’
ingestion period. That fact could be easily observed in GS56
group, where 80% of the animals presented inflammatory
alterations.
Large degeneration areas and zonal necrosis were
present and it was observed ingurgitated necrotic
hepatocyts, with cytoplasmatic and nuclear fragmentation.
In most of the cases they were found gathered, sometimes
surrounded by leukocitary exsudate that involved isolated
hepatocyts or small cellular groups (zonal necrosis), other
times involving the entire liver parenchyma (massive
necrosis) characterizing drug-induced hepatitis similar to a
few other described in the literature.12, 20
The lack of any alteration in the lobular-center vein
suggests that the hepatic alterations produced by sacaca
do not have any relation with those produced by viral
hepatitis. This is due to the fact in our samples we find a
great inflammatory process, while that in the viral hepatitis
it is scarce or nonexistent; when it happens, it is localized
nearby of center-lobular vein and never on the lobular-
center vein, being totally located in the hepatic zone number
three.
Conclusion
The administration of sacaca herbal extract in this
experiment was not able to determine any kind of alteration
in rats’ livers in 14 days of drug administration. However,
when it was used for 28 days, it was possible to observe
hepatocellular alterations in some animals used in this
experiment. Finally, it was observed that all animals which
had the drug for 56 days presented hepatocellular necrosis,
similar to acute hepatitis, concluding that the sacaca toxicity
is dose-dependent.
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